This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20181019 PLA call"
Jump to navigation
Jump to search
(→Agenda) |
|||
| Line 78: | Line 78: | ||
Agenda review | Agenda review | ||
*Notes of [[20181005_PLA_WGM]] review | *Notes of [[20181005_PLA_WGM]] review | ||
| + | *Action items | ||
| + | **Need to look at what we’re calling things vs. what they are. Need to figure out terms that disambiguate what we’ve created. Encourage the organization to clearly delineate what we mean by these names. | ||
| + | **MK will pull up the meeting minutes from the steering divisions to see what they’ve been doing. If steering divisions went away, who would be responsible for those things. | ||
*Discussion Topics | *Discussion Topics | ||
**Management group health metrics | **Management group health metrics | ||
Revision as of 15:34, 19 October 2018
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
| HL7 PLA Call Minutes Location: Phone: +1 770-657-9270, Participant Code: 985371, |
Date: 2018-10-19 Time: 11:30 AM | ||
| Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
| Attendee | Name
| ||
| Calvin Beebe | |||
| Lorraine Constable | |||
| Jean Duteau, | |||
| Tony Julian | |||
| Paul Knapp | |||
| Austin Kreisler, | |||
| Mary Kay McDaniel | |||
| Brian Pech | |||
| Wayne Kubick | |||
| John Roberts | |||
| Andy Stechishin | |||
| no quorum definition | |||
Agenda
Agenda review
- Notes of 20181005_PLA_WGM review
- Action items
- Need to look at what we’re calling things vs. what they are. Need to figure out terms that disambiguate what we’ve created. Encourage the organization to clearly delineate what we mean by these names.
- MK will pull up the meeting minutes from the steering divisions to see what they’ve been doing. If steering divisions went away, who would be responsible for those things.
- Discussion Topics
- Management group health metrics
- notional division of products into product families and lines, to provide examples for peer review.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
Minutes
Convened
Adjourned
Meeting Outcomes
| Actions
|
| Next Meeting/Preliminary Agenda Items |
© 2018 Health Level Seven® International. All rights reserved
